Skip to main content
Caplight Logo









Oncko

Oncko

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.oncko.com/

Last Round

Seed

Feb 1, 2026

Total Funding Raised

$5M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Oncko is a biotechnology company that develops optimized combination drug therapies to treat advanced cancers by leveraging experimental platforms and machine learning.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

drug discoverycombination therapyoncologyprecision medicineAI drug discoveryin silico drug designbiotechcancer researchhigh-throughput screeningcomputational biologydrug optimizationNSCLCCRCnon-small cell lung cancercolorectal cancerpharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Oncko Comparables

Compare Oncko with similar companies based on industry and business-model similarity.

Oncko comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Noetik
74%
PerturbAI
72%
Certis Oncology Solutions
71%

Oncko Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 1, 2026

Key People

Founding team and executive leadership

Atray Dixit

Co-Founder and CEO

Founding Team

Reka Tron

Fractional COO

Executive Team

Oncko Investors

Notable investors and investment history

Oncko investors
InvestorRounds
GaingelsSeed
Adverb VenturesSeed
TenmileSeed
Illumina VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 9, 2026

    Grew 50% QoQ, from 6 to 9 employees.

  • Feb 1, 2026

    $5M round with participation from Gaingels and Illumina Ventures.

Oncko Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Oncko Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Oncko's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range9
Year Founded2024
Last FundingFeb 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?